Clinical studies recruiting near Northridge

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Pa
Phase 4 · Northridge Clinical Trials · Eli Lilly and Company · NCT06857942 Efficacy and Safety of Ribupatide Administered Once Weekly Compared With Semaglutide and Placebo in Participants Living
Phase 3 · Kailera Clinical Site · Kailera · NCT07284979 Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcera
Phase 3 · California Medical Research Associates · Eli Lilly and Company · NCT06937086 A Study to Find Out if BI 764198 Helps Adults and Adolescents With a Kidney Condition Called Focal Segmental Glomerulosc
Phase 3 · Valley Renal Medical Group - Northridge · Boehringer Ingelheim · NCT07220083 A Randomized, Double-Blind, Placebo-Controlled Trial on Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate
Phase 3 · Teva Investigational Site 12161 · Teva Branded Pharmaceutical Products R&D LLC · NCT06664619 This Study is a Non-interventional Disease Registry of Adolescent and Adult Patients With Atopic Dermatitis Who Initiate
Phase N/A · Northridge Clinical Trials, LLC- Site Number : 8400009 · Sanofi · NCT07290803 A Study to Evaluate Finerenone on Clinical Efficacy and Safety in Patients With Heart Failure Who Are Intolerant or Not
Phase 3 · FIN-10407, Northridge, CA · Colorado Prevention Center · NCT06033950 A Study of Dotinurad Versus Allopurinol in Tophaceous Gout
Phase 3 · Amicis Research Center - Balboa · Crystalys Therapeutics · NCT07089888 A Study of the Efficacy and Safety of DMX-200 in Patients With FSGS Who Are Receiving an ARB
Phase 3 · Amicis Research Centre · Dimerix Bioscience Pty Ltd · NCT05183646 Efficacy and Safety of Orforglipron in Participants With Peripheral Artery Disease
Phase 3 · Valley Clinical Trials, LLC dba Flourish Research · Eli Lilly and Company · NCT07223593 A Study to Evaluate Brenipatide Compared With Placebo in Adult Participants With Uncontrolled Moderate to Severe Asthma
Phase 2 · California Medical Research Associates · Eli Lilly and Company · NCT07219173 An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerabilit
Phase 3 · Valley Clinical Trials · Novartis Pharmaceuticals · NCT07517263 Maridebart Cafraglutide Versus Placebo in Adult Participants With Obstructive Sleep Apnea Not on Positive Airway Pressur
Phase 3 · Valley Clinical Trials · Amgen · NCT07226765 Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Dee
Phase 3 · Anthos Investigative Site 1015 · Anthos Therapeutics, Inc. · NCT05712200 Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Ob
Phase 3 · California Medical Research Associates · Eli Lilly and Company · NCT06937099 Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease o
Phase 3 · Clinical Trial Site · Alnylam Pharmaceuticals · NCT07181109 A Study of Dotinurad Versus Allopurinol in Participants With Gout
Phase 3 · Amicis Research Center - Balboa · Crystalys Therapeutics · NCT07089875 To Evaluate the Effect of EXPD-101/FXS7553 Compared With Placebo in Patients With COPD Over 52 Weeks of Treatment
Phase 2 · California Medical Research Associates Inc. · Expedition Therapeutics, Inc · NCT07684820 Pelacarsen Roll-over Extension Program
Phase 3 · California Medical Research Associates Inc · Novartis Pharmaceuticals · NCT06875973 OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardio
Phase 3 · Valley Clinical Trials · Amgen · NCT07136012 A Study to Evaluate the Pharmacodynamics of a Combination of QCZ484 and Inclisiran in Participants With Hypertension and
Phase 2 · Valley Clinical Trials · Novartis Pharmaceuticals · NCT07610278 A Study to Investigate GB-0895 Adjunctive Therapy in Adults and Adolescents With Severe Uncontrolled Asthma (SOLAIRIA-1)
Phase 3 · Research Site 23 · Generate Biomedicines · NCT07276724 A Phase 2b Study of the Effects of Camoteskimab in Adults With Moderate-to-Severe Atopic Dermatitis
Phase 2 · Northridge Clinical Trials · Apollo Therapeutics Ltd · NCT07599813 Safety and Efficacy of VDPHL01 in Females With Androgenetic Alopecia (AGA)
Phase 3 · Site 93 · Veradermics, Inc. · NCT07146022 A Study to Evaluate the Efficacy, Safety, and Drug Levels of Deucravacitinib (BMS-986165) in Adolescent Participants Wit
Phase 3 · Northridge Clinical Trials · Bristol-Myers Squibb · NCT06979453 Efficacy and Safety of Oral KAI-7535 in Adult Participants Living With Obesity or Overweight With at Least 1 Weight-Rela
Phase 2 · Kailera Clinical Site · Kailera · NCT07497880 A Study to Evaluate AZD7760 Safety and Pharmacokinetics in Healthy Adults (Phase I) and Adults With End-stage Kidney Dis
Phase 1/Phase 2 · Research Site · AstraZeneca · NCT06749457 Assessment of CCM in HF With Higher Ejection Fraction
NA · Valley Clinical Trials- Northridge · Impulse Dynamics · NCT05064709 A Study To Learn About Two Study Medicines (PF-07275315 And PF-07264660) In People Who Have Moderate To Severe Atopic De
Phase 2 · Northridge Clinical Trials · Pfizer · NCT05995964 A 16-Week Study to Learn About the Study Medicine Called Ritlecitinib in Adults With Long Lasting Painful Red Skin Lumps
Phase 2 · Northridge Clinical Trials · Pfizer · NCT07228390

Look up another city

Look up another condition